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d-HT INHIBITION OF RAT INSULIN 2 PROMOTER Cre RECOMBINASE
RANSGENE AND PROOPIOMELANOCORTIN NEURON EXCITABILITY
N THE MOUSE ARCUATE NUCLEUS
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bstract—A number of anti-obesity agents have been devel-
ped that enhance hypothalamic 5-HT transmission. Various
tudies have demonstrated that arcuate neurons, which ex-
ress proopiomelanocortin peptides (POMC neurons), and
europeptide Y with agouti-related protein (NPY/AgRP) neu-
ons, are components of the hypothalamic circuits responsi-
le for energy homeostasis. An additional arcuate neuron
opulation, rat insulin 2 promoter Cre recombinase trans-
ene (RIPCre) neurons, has recently been implicated in hy-
othalamic melanocortin circuits involved in energy balance.
t is currently unclear how 5-HT modifies neuron excitability
n these local arcuate neuronal circuits. We show that 5-HT
lters the excitability of the majority of mouse arcuate RIPCre
eurons, by either hyperpolarization and inhibition or depo-
arization and excitation. RIPCre neurons sensitive to 5-HT,
redominantly exhibit hyperpolarization and pharmacologi-
al studies indicate that inhibition of neuronal firing is likely
o be through 5-HT1F receptors increasing current through a
oltage-dependent potassium conductance. Indeed, 5-HT1F
eceptor immunoreactivity co-localizes with RIPCre green flu-
rescent protein expression. A minority population of POMC
eurons also respond to 5-HT by hyperpolarization, and this
ppears to be mediated by the same receptor-channel mech-
nism. As neither POMC nor RIPCre neuronal populations
isplay a common electrical response to 5-HT, this may indi-
ate that sub-divisions of POMC and RIPCre neurons exist,
erhaps serving different outputs. © 2009 IBRO. Published by
lsevier Ltd.
ey words: 5-HT, hypothalamus, K channel, RIPCre, POMC,
-HT1F receptor.
he CNS control of food intake involves complex interac-
ions between circulating hormones, nutrients, neuropep-
ides, monoamines and other neurotransmitters. These act
t a variety of hypothalamic areas (including the paraven-
ricular nucleus (PVN) and the lateral (LHA) and medial
Corresponding author. Tel: 44-1382-636702; fax: 44-1382-667120.
-mail address: m.l.j.ashford@dundee.ac.uk (M. Ashford).
bbreviations: AgRP, agouti-related protein; ARC, arcuate nucleus;
FP, green fluorescent protein; LHA, lateral hypothalamic area; NPY,
europeptide Y; PBG, 1-phenylbiguanide; POMC, proopiomelanocor-
in; PVN, paraventricular nucleus; RIPCre, rat insulin 2 promoter Cre
ecombinase transgene; TEA, tetraethylammonium chloride; TTX, tetro-
otoxin; -me 5-HT, -methyl 5-HT; -MSH, alpha-melanocyte stimulat-
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ng hormone; Vm, change in membrane potential; 5-CT, 5-carboxam-
dotryptamine; 8-OH-DPAT, 8-hydroxy-2-(di-n-propylamino) tetralin.
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Open access under CC BY licenypothalamic areas) to modulate orexigenic and anorexi-
enic neural pathways (Broberger, 2005). At least two
opulations of neurons within the arcuate nucleus (ARC) of
he hypothalamus contribute to the central circuitry that
ontrols energy homeostasis. These neurons make up part
f the melanocortin pathway, which consists of cells con-
aining neuropeptide Y (NPY) along with the endogenous
elanocortin antagonist, agouti-related protein (AgRP)
nd cells containing alpha-melanocyte stimulating hor-
one (-MSH) and other proopiomelanocortin (POMC)
erived peptides (Ellacott and Cone, 2004; Cone, 2005).
hese neurons are key targets for the hormones leptin and
nsulin, the actions of which effect an anorexigenic output
Niswender et al., 2004).
Food intake is accompanied by changes in the release
f monoamines in the hypothalamus (Schwartz et al.,
990), and sympathomimetic drugs (e.g. d-fenfluramine)
ave long been used to reduce food intake and appetite
Ioannides-Demos et al., 2005). Consequently, pharmaco-
ogical manipulation that results in enhancement or inhibi-
ion of 5-HT synaptic transmission reduces and increases
ood intake, respectively, in animals and humans (Halford
t al., 2005). Electrophysiological recordings from neurons
f transgenic mice expressing green fluorescent protein
GFP) under the control of the POMC promoter demon-
trate that 5-HT depolarizes arcuate POMC neurons (He-
sler et al., 2002), an action also observed for leptin (Cow-
ey et al., 2001; Choudhury et al., 2005). There are at least
4 different 5-HT receptor subtypes and many are present
t significant levels in the hypothalamus, notably 5-HT1B,
-HT1F, 5-HT2A, 5-HT2B, 5-HT2C and 5-HT7 (Hoyer et al.,
002). However, it is still unclear exactly which 5-HT re-
eptor subtypes contribute to modulation of activity in the
ypothalamic circuits that sub-serve long-term control of
ood intake and energy expenditure. In addition, the un-
erlying mechanisms by which 5-HT receptor activation
lters the electrical activity of these ARC neurons are
nknown. Studies, using selective 5-HT receptor subtype
gonists and antagonists, have demonstrated both hy-
erphagic and hypophagic responses in animal studies.
nfortunately, many of these ligands lose their receptor
electivity at higher concentrations, resulting in some un-
ertainty over receptor subtype identity in relation to
hanges in food intake. Nevertheless, there are two main
ubtypes proposed as key mediators of the anorexigenic
ction of 5-HT, the 5-HT1B and 5-HT2C receptors (Ramos
t al., 2005). Neurons expressing 5-HT1B (Makarenko et
l., 2002) and 5-HT receptors (Clemett et al., 2000) are2C
resent in hypothalamic feeding centers (i.e. PVN, LHA
se.
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K. Hisadome et al. / Neuroscience 159 (2009) 83–9384nd ARC), but are also found in brain areas not implicated
n energy homeostasis (Hoyer et al., 2002). The 5-HT2C
eceptor knockout mouse demonstrates increased food
ntake and obesity (Tecott et al., 1995) and the hypophagic
ction of d-fenfluramine is attenuated in the 5-HT1B knock-
ut mouse (Lucas et al., 1998). However, global 5-HT1B
nd 5-HT2C receptor knockout mice also develop physio-
ogical abnormalities such as seizures, anxiety and ag-
ression (Tecott et al., 1995; Ramboz et al., 1996). These
bservations highlight the multi-functional role of the sero-
onergic system, but also raise the question whether the
eeding behaviors observed are due to the lack of a given
eceptor in the energy regulatory centers and/or in areas
ssociated with other physiological or pathological out-
omes. In addition, although histochemical and in situ
ybridization studies demonstrate that many 5-HT receptor
ubtypes are located in energy regulatory centers, these
ata provide no information about receptor-mediated alter-
tion of neuronal function, most importantly in relation to
hanges in neuronal excitability.
Recent studies have indicated that another population
f arcuate neurons, defined by GFP expression driven by
he rat insulin 2 promoter Cre recombinase transgene
RIPCre), which are distinct from NPY/AgRP and POMC
eurons, are involved in the regulation of body weight and
nergy homeostasis (Cui et al., 2004; Choudhury et al.,
005). Thus, we have examined the actions of 5-HT on the
lectrical activity of this population of arcuate neurons and
how that they respond to 5-HT in a heterogeneous man-
er with the majority of responding neurons displaying
yperpolarization and reduced excitability.
EXPERIMENTAL PROCEDURES
ypothalamic slice preparation
s previously described (Choudhury et al., 2005; Smith et al., 2007)
e have used 2 Cre recombinase transgenic lines, RIPCre and
OMCCre and inter-crossed these with the ZEG indicator mouse to
enerate mice with GFP expression in selective hypothalamic neu-
onal populations. All procedures conformed to the UK Animals (Sci-
ntific Procedures) Act 1986, and were approved by our institutional
thical review committee. Every effort was made to minimize the
umber of animals used and their suffering. RIPCreZEG and POM-
CreZEG mice (8–16 weeks old) were killed by cervical dislocation;
he brain was rapidly removed and submerged in an ice cold slicing
olution containing (in mM) KCl 2.5, NaH2PO4 1.25, NaHCO3 28,
aCl2 0.5, MgCl2 7, D-glucose 7, ascorbate 1, pyruvate 3 and su-
rose 235, equilibrated with 95% O2, 5% CO2 to give a pH of 7.4.
ypothalamic coronal slices (350 m), containing the ARC, were cut
sing a Vibratome (St Louis, MO, USA), transferred and kept at room
emperature (22–25 °C) in an external solution containing (in mM)
aCl 125, KCl 2.5, NaH2PO4 1.25, NaHCO3 25, CaCl2 2, MgCl2
, D-glucose 10, D-mannitol 15, ascorbate 1 and pyruvate 3, equil-
brated with 95% O2, 5% CO2, pH 7.4.
lectrophysiology
ndividual arcuate neurons were identified by epifluorescence and
ifferential interference contrast optics using an upright Zeiss
xioskop-2 FS plus microscope. Slices were continually perfused
ith a modified external solution (0.5 mM CaCl2 and 2.5 mM
gCl , no ascorbate and pyruvate) at a flow rate of 5–10 ml/min2
nd a bath temperature of 33 °C. For high potassium experiments, fhe normal external solution was replaced with a solution contain-
ng (in mM) NaCl 130, KCl 20, CaCl2 0.5, MgCl2 2.5, D-glucose 10,
-mannitol 15, Hepes 10, pH 7.4. Patch-clamp recordings were
erformed using borosilicate patch pipettes (4–8 M) filled with
n internal solution containing (in mM) K-gluconate 130, KCl 10,
GTA 0.5, Hepes 10, NaCl 1, CaCl2 0.28, MgCl2 3, Na2ATP 3,
ris-GTP 0.3, phosphocreatine 14 (pH 7.2). Whole-cell series re-
istance (Rs) was compensated using an Axopatch 200B amplifier
Molecular Devices, Sunnyvale, CA, USA) in current (Ifast) and
oltage-clamp modes (Rs: 30–60 and 10–30 M respectively).
oltage and current commands were manually or externally driven
sing PClamp 9.2 software and injected into neurons via the patch-
lamp amplifier. Under current clamp, hyperpolarizing current pulses
between 5 and 20 pA, at a frequency of 0.05 Hz) were used to
onitor input and series resistance at resting membrane potentials.
n addition, input resistance was calculated from I–V relationships
voked from a holding potential of 70 mV (5–30 pA, 0.5 s pulse
uration). Voltage clamp recordings of transient voltage-dependent
otassium (IA) conductance and the delayed and inward rectifying
otassium conductances were performed as described in Smith et al.
2007). Whole cell currents and voltages were filtered at 5 and 2 kHz
espectively, and digitized at 50 kHz using Pclamp 9.2 software. All
ata were stored un-sampled on digital audiotape for off-line analysis
sing Clampex 9.2 or Igor pro. Membrane potentials were either
eplayed un-sampled on an EasyGraph TA240 chart recorder
Gould, Ballainvilliers, France), or digitized and imported into Abode
llustrator for illustration purposes.
Drugs were added to the external solution and applied to
lices via the perfusion system or locally applied using a broken
ipped pipette (4 m diameter) positioned above the recording
eurons, as previously described (Choudhury et al., 2005). At
east 10 min of stable control data were recorded before the
pplication of any drug, and antagonists were applied for at least
0 min prior to challenge with agonist. Neuronal integrity was
etermined by biophysical and gross anatomical assessment, as
escribed previously (Smith et al., 2007; Claret et al., 2007).
mmunocytochemistry
ypothalamic sections (30 m) from paraformaldehyde perfused
rains were processed as previously described (Choudhury et al.,
005). Primary antibodies used were rabbit polyclonal antibodies
aised to the C- or N-terminal domains of the 5-HT1F receptor and
ere obtained from MBL International (MA, USA; cat No. LS-3344
nd LS-3338, respectively). Slices were incubated with primary
ntibody (1:300 dilution) for 48 h at 4 °C, following which they were
ncubated with anti-rabbit secondary antibody conjugated to Alexa
luor 549 (1:800 dilution) for 1 h. RIPCre-GFP expression and
-HT1F receptor localization were detected using a confocal mi-
roscope (BioRad MRC 100).
CR
475 base pair fragment encoding a region of the 5-HT1F receptor
as detected by PCR from mRNA extracted from mouse hypothal-
mus using the following primers: forward GGAAGCTGAGTT-
AGATGATGGC, reverse CACGTACAACAGATGATGTCG.
hemicals
ynurenic acid, () bicuculline, tetraethylammonium chloride (TEA),
-aminopyridine (4-AP), barium chloride, 5-HT, 8-hydroxy-2-(di-n-
ropylamino) tetralin (8-OH-DPAT), SB 242084 and CGS 12066B
ere purchased from Sigma-Aldrich (Dorset, UK). -Methyl 5-HT
-me 5-HT), 5-carboxamidotryptamine (5-CT), ketanserin, methio-
hepin, SB 204741, BW 723C86, CP 93129, SB 224289, L 694247
nd BRL 54443 were obtained from Tocris Bioscience (Bristol, UK),
etrodotoxin (TTX) from Alomone Laboratories, Ltd. (Jerusalem, Is-
ael), and zacopride from Professor B. Costell (University of Brad-
ord). All drugs were dissolved in saline immediately before use.
SR
n
p
s
t
q
t
p
n
a
t
t
5
t
s
5
W
R
e
a
2
i
G
t

t
b
w
5
t
i
n
2
1
i
i

r
v
p
F
p
r
d
e
r
f
h
t
e
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esponsive neurons were distinguished from non-responding
eurons based on the criterion that the change in membrane
otential (Vm) induced by the drug challenge was 3 times the
tandard deviation of the mean membrane potential prior to addi-
ion of the drug (Smith et al., 2007; Claret et al., 2007). Conse-
uently, a neuron was considered hyperpolarized or depolarized if
he membrane potential was altered by 3 mV. Results are ex-
ressed as the meanS.E.M. of the defined responses, with the
umber of cells studied. Statistical significance was determined on
ll neurons examined within a data set using a Student’s two-
ailed paired t-test or ANOVA, followed by Bonferroni’s post hoc
est, where appropriate. Comparisons between 5-HT  agonist or
-HT  antagonist on neuron responses were made by paired
wo-tailed Student’s t-test. A P value of less than 0.05 was con-
idered statistically significant.
RESULTS
-HT modulates the excitability of RIPCre neurons
hole-cell current-clamp recordings were made from
IPCre hypothalamic arcuate neurons identified by the
xpression of GFP. Under control recording conditions,
ig. 1. 5-HT alters the excitability of RIPCre neurons. Whole-cell cu
resence of 5-HT. (A) The predominant response to bath applied 5-HT
eadily reversible and a second application of 5-HT produced the sam
epolarization and increased excitability. A diary plot of firing freque
xcitation. (C) The remaining proportion of RIPCre neurons tested was
egions of this recording are displayed to show more clearly that bat
requency is shown for this neuron. (D) Increasing doses of 5-HT wer
yperpolarization. Increasing the duration of pressure ejection of 5-HT
hat increasing the dose of 5-HT did not induce receptor desensitization at the t
vidence for heterogeneity of response to 5-HT.nd consistent with previous reports (Choudhury et al.,
005; Smith et al., 2007) RIPCre neurons were character-
zed (n111) by a high mean input resistance, 1.50.1
, and spontaneously fired sodium mediated action po-
entials from a mean resting membrane potential of
57.00.5 mV at a frequency of 4.00.2 Hz. Changes in
he electrical excitability of RIPCre neurons (as assessed
y changes in membrane potential and firing frequency)
ere elicited by bath (1 M) or locally (2–5 M) applied
-HT with no discernable difference in the output in relation
o the method of application. Application of 5-HT resulted
n clear heterogeneous responses in this population of
eurons. Overall, 5-HT inhibited 50% (55/111), excited
5% (28/111) or did not alter the excitability of 25% (28/
11) of RIPCre neurons. In neurons, which displayed an
nhibitory response to 5-HT there was a rapid hyperpolar-
zation (Fig. 1A) from a mean membrane potential of
50.60.8 mV to 63.31.1 mV (n55, P0.05), which
esulted in a decrease in neuronal firing rate, from a mean
alue of 4.10.3 Hz to 0.60.2 Hz (P0.05). This hyper-
olarization and reduction in excitability was accompanied
p recordings were made from RIPCre neurons in the absence and
was hyperpolarization and inhibition of firing. This action of 5-HT was
. (B) A smaller proportion of RIPCre neurons responded to 5-HT by
his neuron is shown, with bath-applied 5-HT demonstrating a clear
e to 5-HT, with no evidence of a Vm or of firing frequency. Expanded
5-HT had no effect on membrane potential. The diary plot of firing
applied to a RIPCre neuron, shown previously to respond to 5-HT by
s) increased the magnitude and duration of the 5-HT response. Noterrent clam
(1 M)
e effect
ncy for t
insensitiv
h-applied
e locally-
(5 s–25ime intervals used for successive 5-HT challenges, and there was no
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K. Hisadome et al. / Neuroscience 159 (2009) 83–9386y a decrease in whole-cell input resistance from a mean
alue of 1.500.09 G to 1.240.23 G (P0.05), indi-
ating that an increase in conductance underlies this re-
ponse. 5-HT-mediated hyperpolarizing or depolarizing
euronal responses (n8) were also obtained (data not
hown) from slices exposed to 0.5 M TTX. RIPCre neu-
ons that were excited by 5-HT, were rapidly depolarized
Fig. 1B) from a mean membrane potential of 52.41.1
V to 47.21.2 mV (n28, P0.05), and this was ac-
ompanied by an increase in firing rate from a mean value of
.10.5 Hz to 5.20.8 Hz (P0.05). The depolarization and
ncreased firing were not accompanied by any significant
hange in whole-cell input resistance (from 1.600.11 G to
.680.13 G). In RIPCre neurons where electrical activity
as unaffected by application of 5-HT (Fig. 1C), there was no
ignificant change in either resting membrane potential
50.00.9 mV to50.40.9 mV) or firing rate (4.60.5 Hz
o 4.90.6 Hz).
ig. 2. 5-HT2 receptors are not responsible for 5-HT-induced RIPCre
embrane potential or firing frequency of a RIPCre neuron, which had
xpanded traces and the corresponding diary plot of firing frequency
0 M mimicked the depolarizing effect of 5-HT on the same RIPCre n
hat the depolarization of this neuron by either agonist was sufficient
-HT2C antagonist, SB242084 (100 nM) (D) ketanserin (10 nM) or (E) t
rom depolarizing and increasing the firing frequency of RIPCre neurons. (F) Ap
n the excitability of RIPCre neurons that responded to 5-HT by depolarizationWe found no evidence for any dose-dependent effect
f 5-HT with respect to these alterations in excitability;
IPCre neurons responded to 5-HT by hyperpolarization,
epolarization or no response regardless of concentration
up to 10 M tested) or duration of 5-HT application. An
xample of such a single reproducible outcome is shown in
ig. 1D, where increasing amounts of 5-HT were pressure
jected (by altering the duration of pressure application)
nto a RIPCre neuron, previously shown to respond to
-HT by hyperpolarization. A dose-dependent increase in
he hyperpolarizing response amplitude and duration was
bserved (n3), with no evidence for the direction of the
esponse being dependent upon the duration (dose) of
-HT ejection. The changes in membrane potential and
pike firing induced by 5-HT (and other agonists, see
elow) at the concentrations utilized in this study on
IPCre neurons were reversible on washout within 15–30
in. Moreover, no desensitization of response to 5-HT or
depolarization. (A) Bath-applied -me 5-HT (1 M) did not affect the
own previously to respond to 5-HT with depolarization (upper trace).
euron are shown. (B) Increasing the concentration of -me 5-HT to
e expanded traces (lower) show the depolarization more clearly. Note
severe action potential truncation. The presence of (C) the selective
B antagonist SB204741 (100 nM) did not prevent locally-applied 5-HTneuron
been sh
for this n
euron. Th
to cause
he 5-HT2plication of 5 M BW72C86, a selective 5-HT2B agonist, had no effect
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K. Hisadome et al. / Neuroscience 159 (2009) 83–93 87gonists was observed when re-applied following several
inutes of washout (e.g. Fig. 1A, D). In subsequent ex-
eriments, detailed below, selective agonists and antago-
ists were applied to RIPCre neurons following an initial
-HT challenge, which was used to ascertain the category
f the response (depolarizing, hyperpolarizing or non-re-
ponsive).
-HT modulation of RIPCre neuron excitability is
ndependent of 5-HT2 receptors
previous study has reported that 5-HT depolarizes
OMC neurons via the activation of 5-HT2C receptors
Heisler et al., 2002). To determine whether the depolar-
zing response observed in RIPCre neurons is also medi-
ted by this receptor subtype, we first attempted to mimic
he 5-HT depolarizing response on RIPCre neurons with a
elective 5-HT2 receptor agonist, -me 5-HT. At a concen-
ration (1 M) reported (Acuna-Castillo et al., 2002) to be
elatively selective for 5-HT2A/2C receptors, -me 5-HT did
ot alter the excitability (Fig. 2A) of RIPCre neurons,
hown to respond to 5-HT by depolarization (5-HT,
Vm4.71.5 mV; -me 5-HT, Vm1.50.8 mV,
3, P0.05) neurons. Increasing the concentration of
-me 5-HT to 10 M resulted in depolarization (5-HT,
Vm5.40.7 mV; -me 5-HT, Vm6.62.2 mV;
3) of RIPCre neurons (Fig. 2B), perhaps indicative of
oss of selectivity to this agonist at a higher concentration.
herefore, we attempted to block the effects of 5-HT with
elective receptor antagonists at concentrations where
hey have been reported to retain their selectivity. How-
ver, the presence of 100 nM SB242084, a selective
-HT2C receptor antagonist (Kennett et al., 1997b), failed
Fig. 2C) to prevent 5-HT from depolarizing RIPCre neu-
ons (5-HT, Vm4.20.8 mV; 5-HTSB242984,
Vm6.51.7 mV, n3). Furthermore, addition of
00 nM ketanserin to the bath solution, a concentration
hat will antagonize both 5-HT2A and 5-HT2C receptors
Baxter et al., 1995) also did not prevent 5-HT from depo-
arizing (Fig. 2D) RIPCre neurons (5-HT, Vm5.91.1
V; 5-HTketanserin, Vm7.30.5 mV, n3). The
elective 5-HT2B antagonist (Baxter et al., 1995), SB204741
100 nM) was also incapable (Fig. 2E) of blocking the 5-HT
ig. 3. 5-HT2 receptors do not mediate RIPCre neuron hyperpolariza
etanserin (100 nM) or (C) SB204741 (100 nM) did not prevent 5-HT from hyperp
id not mimic the hyperpolarizing action of 5-HT. The time gap in the recordinepolarizing response in RIPCre neurons (5-HT, Vm
5.81.6 mV; 5-HTSB204741, Vm8.54.8 mV, n3).
he selective 5-HT2B receptor agonist (Kennett et al., 1997a),
W723C86 (5M)was also unable tomimic (Fig. 2F) the 5-HT
epolarization of RIPCre neurons (5-HT, Vm5.21.9 mV;
W723C86, Vm0.90.5 mV, n3). The 5-HT3 receptor
ith its intrinsic non-selective cation channel, which depolarizes
eurons when activated (Peters et al., 1992) is an attractive
andidate to explain the 5-HT depolarization observed. How-
ver, bath application of the selective (Kilpatrick et al., 1990)
-HT3 receptor agonist 1-phenylbiguanide (PBG; 1M), did not
ffect the resting membrane potential or firing frequency of
IPCre neurons (data not shown), previously demonstrated to
espond to bath application of 5-HT by depolarization (5-HT,
Vm5.71.2 mV; PBG, Vm0.541.3 mV, n4).
Similarly the hyperpolarizing response elicited by 5-HT in
IPCre neurons was not mediated by a 5-HT2 receptor sub-
ype. Thus, in RIPCre neurons inhibited by 5-HT, the pres-
nce of 100 nM SB242084 (5-HT, Vm16.91.4 mV;
-HTSB242084, Vm16.62.1 mV, n3), 100 nM ket-
nserin (5-HT, Vm15.02.9 mV; 5-HTketanserin,
Vm14.53.4 mV, n3) or 100 nM SB204741 (5-HT,
Vm17.15.2 mV; 5-HTSB204741, Vm20.44.4
V, n3) did not reduce the hyperpolarizing response in-
uced by local application of 5-HT (Fig. 3A–C). Additionally,
he 5-HT2B selective agonist, BW723C86 (5 M) was also
nable to mimic the 5-HT hyperpolarization response (Fig.
D) on RIPCre neurons (5-HT, Vm14.16.8 mV;
W723C86, Vm2.01.8 mV, n3). Overall, these data
ndicate that 5-HT utilizes 5-HT receptors other than those of
he 5-HT2 receptor subtype to elicit modification of RIPCre
euronal excitability.
-HT1 receptors mediate hyperpolarization of RIPCre
eurons
s the hyperpolarizing response to 5-HT on RIPCre neu-
ons was the dominant outcome electrically, we decided to
ocus on this response. Consequently we examined, using
elective pharmacology, which of the remaining 5-HT re-
eptor subtypes was likely responsible. Zacopride is a
-HT3 receptor antagonist and a 5-HT4 receptor agonist
Schiavi et al., 1994). However, RIPCre neurons (Fig. 4A)
-HT (local application). The presence of (A) SB242084 (100 nM), (B)tion by 5
olarizing RIPCre neurons. (D) Local application of BW723C86 (5 M)
g shown in (B) is 38 min.
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K. Hisadome et al. / Neuroscience 159 (2009) 83–9388hat were hyperpolarized by 5-HT, did not respond to
00 M zacopride (5-HT, Vm7.93.1 mV; zacopride,
Vm1.82.1 mV, n3). In contrast, application of the
ixed 5-HT1,5,7 receptor agonist 5-CT (2 M) reversibly
yperpolarized (Fig. 4B) RIPCre neurons (5-HT, Vm
11.60.6 mV; 5-CT, Vm13.32.2 mV, n4). In an at-
empt to distinguish between the 5-HT1,5,7 receptor subtypes,
e examined the responsiveness of RIPCre neurons to 5-HT in
he presence of 200 nMmethiothepin (a concentration expected
o bind and antagonize 5-HT2A,2C and 5-HT5,6,7 receptor sub-
ypes; Hoyer et al., 1994). However, this concentration of me-
hiothepin had no effect (Fig. 4C) on the inhibitory action of 5-HT
n RIPCre neurons (5-HT, Vm14.75.9 mV; 5-HT
ethiothepin, Vm13.95.6 mV, n4). In contrast, 2 M
ethiothepin, (Fig. 4C) completely inhibited the hyperpolarizing
ction of 5-HT on these neurons (5-HT, Vm11.93.4 mV;
-HTmethiothepin, Vm0.70.5 mV, n4). Conse-
uently, these data point toward the 5-HT1 receptor subtype
amily as likely responsible for the 5-HT-mediated hyperpolar-
zation of RIPCre neurons.
It has previously been demonstrated that 5-HT1A recep-
or activation induces hyperpolarization of hypothalamic (Mu-
aki et al., 2004) and dorsal raphe (Katayama et al., 1997)
eurons. However, application of the 5-HT1A receptor-pref-
rential agonist, 8-OH-DPAT, which also acts as a 5-HT5
eceptor agonist at the concentrations employed here
10 M), did not mimic (Fig. 4D) 5-HT-induced hyperpolar-
zation of RIPCre neurons (5-HT, Vm8.43.4 mV;
-OH-DPAT, Vm1.40.7 mV, n3). 5-HT1B receptor
nockout mice have been reported to display reduced sen-
itivity to the anorexigenic actions of d-fenfluramine (Lucas et
l., 1998). The selective rodent 5-HT receptor agonist
ig. 4. 5-HT1 receptors mediate RIPCre neuron hyperpolarization by
eurons by 5-HT. (B) Local application of 5-CT (1 M) hyperpolarized a
C) 5-HT-mediated hyperpolarization of RIPCre neurons was insensit
M methiothepin (lower trace). Local application of (D) 8-OH DPAT
ction of 5-HT. (F) The presence of SB22489 (100 nM) did not preve1B
GS12066B (1 M) did not induce RIPCre neuron hyperpo- sarization (5-HT, Vm9.23.3 mV; CGS12066B, Vm
0.80.5 mV, n3) (Fig. 4E). Moreover, the presence of
B224289, at a concentration (100 nM) that specifically an-
agonizes 5-HT1B receptors (Selkirk et al., 1998) was unable
o prevent 5-HT induced hyperpolarization (5-HT, Vm
17.73.5 mV; 5-HTSB224289, Vm16.72.6 mV,
3; Fig. 4F) of RIPCre neurons. Consequently, we exam-
ned other 5-HT1 receptor subtype-specific agonists. The se-
ective 5-HT1D agonist (Beer et al., 1993), L694247 (2 nM),
ad no effect on RIPCre neuron membrane potential (5-HT,
Vm10.32.5 mV; L694247,Vm1.10.5 mV, n3;
ig. 5A). In contrast, the mixed 5-HT1E,1F receptor agonist
RL54443 at a concentration (20 nM) that retains selectivity
or these subtypes (Brown et al., 1998) hyperpolarized (Fig.
B) RIPCre neurons (5-HT, Vm11.02.1 mV,
RL54443, Vm5.30.8 mV, n5). There is no evi-
ence for 5-HT1E receptor expression in mouse (Bai et al.,
004) and our PCR analysis demonstrates the presence of
-HT1F mRNA in mouse hypothalamic tissue blocks (Fig.
C). Thus, in order to corroborate the presence of 5-HT1F
eceptors in mouse arcuate neurons, we performed immuno-
istochemistry for 5-HT1F receptors. In control experiments,
oth 5-HT1F receptor antibodies displayed immunoreactivity
n various brain regions, but not in heart, consistent with the
xpression profile for this receptor (Lovenberg et al., 1993).
sing hypothalamic slices from RIPCreGFP mice and two
ifferent 5-HT1F receptor antibodies (raised to separate
pitopes of this receptor), 5-HT1F receptors were demon-
trated to be present in the hypothalamus, with high levels in
he ARC (Fig. 5D). As is expected for membrane receptors,
-HT1F immunoreactivity appeared as small (1 m) distinct
uncta that co-localized with the plasma membrane on the
) Zacopride (2 M) could not mimic the hyperpolarization of RIPCre
ited the firing of RIPCre neurons, in a manner identical to that of 5-HT.
ck by 200 nM methiothepin (upper trace), but could be prevented by
or (E) CGS12066B (1 M) was unable to mimic the hyperpolarizing
rom hyperpolarizing RIPCre neurons.5-HT. (A
nd inhib
ive to blooma and neurites. Many RIPCreGFP positive neurons ex-
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K. Hisadome et al. / Neuroscience 159 (2009) 83–93 89ressed 5-HT1F receptors (circled in Fig. 5D), although oc-
asional GFP positive neurons without significant 5-HT1F
taining could also be observed (e.g. white arrow in Fig. 5D),
onsistent with the notion that a significant sub-population of
IPCre neurons does not respond to 5-HT by hyperpolariza-
ion. In addition, numerous non-GFP cells in the ARC showed
ignificant staining for the 5-HT1F receptor (e.g. squares in
ig. 5D), supporting the view that 5-HT1F receptor expression
s not limited to a single neuronal phenotype.
RL54443 inhibits RIPCre neurons by increasing a
oltage-dependent K conductance
n an attempt to identify the conductance(s) modulated by
RL54443 that give rise to the hyperpolarizing response,
IPCre neurons were voltage-clamped in an external so-
ution containing 10 M bicuculline, 2 mM kynurenic acid
nd 1 M TTX to block synaptic transmission and regen-
rative Na spikes. Neurons were held at 70 mV and
oltage pulses (500 ms duration) were stepped from 90
o 10 mV in 5 mV increments, with a 5 ms pre-pulse
tepped to 170 mV to deactivate voltage dependent
otassium conductances (Fig. 6A). As described for
OMC (Roseberry et al., 2004) and RIPCre (Smith et al.,
007) neurons, the inward rectifier potassium (KIR) con-
uctance in arcuate neurons is extremely small under our
ontrol recording conditions. To increase the magnitude
ig. 5. RIPCre neurons are hyperpolarized by BRL54443, a 5-HT1E/F a
1 nM) did not alter RIPCre neuron membrane potential or firing fre
yperpolarized and inhibited the firing of RIPCre neurons that respond
in. (C) RT-PCR detection of the 5-HT1F receptor transcript in (i) whole
onfocal image of the ARC captured in 1 m serial sections. Dual flu
ed), 5-HT1F receptors can be observed on both GFP-positive (wh
FP-positive neurons display little or no immunoreactivity (e.g. white a
mages (data not shown). 3v, Third ventricle. Scale bar20 m in (D).
eferred to the Web version of this article.nd induce a shift in the reversal potential (to approxi- sately 50 mV) of the KIR conductance, the external
otassium concentration was raised from 2.5–20 mM
Smith et al., 2007). We have previously shown (Smith et
l., 2007), for RIPCre neurons, that the KIR conductance is
locked by 100 M Ba2, the transient voltage-dependent
otassium (IA) conductance by 4 mM 4-aminopyridine, and
he delayed rectifier type voltage-dependent potassium
onductance partly blocked by 40 mM external TEA (see
lso Fig. 6B). Use of these blockers allowed identification
nd relative isolation of the main potassium currents ob-
erved in these neurons under our recording conditions.
ocal application of 20 nM BRL54443 to RIPCre neurons
ad no effect on KIR, with a linear slope conductance
measured between 90 and 50 mV) in 20 mM [Ko] of
.60.5 nS in control and 1.60.5 nS (n8) in the pres-
nce of BRL54443 (data not shown). Similarly, 20 nM
RL54443 did not significantly change the peak amplitude
f IA (measured at 10 mV; 1126% of control, P	0.05,
8). In contrast, 20 nM BRL54443 reversibly increased
he steady state depolarization-activated potassium cur-
ent (measured at the end of the10 mV command pulse)
y 368% (P0.05, n8, Fig. 6C, D).
yperpolarization of POMC neurons
hole-cell current clamp recordings were made from
OMC neurons, identified by expression of GFP, under the
d express 5-HT1F receptors. (A) The 5-HT1D receptor agonist, L69247
The gap in the recording shown is 17 min. (B) BRL54443 (20 nM)
perpolarization to 5-HT. The gap in the recording (upper trace) is 22
rain and (ii), (iii) in separate mouse hypothalami. (D) Stacked (30 m)
e for GFP (green) and 5-HT1F receptor (N-terminal domain antibody:
s) and GFP-negative (white squares) cells, although a minority of
ote the C-terminal domain 5-HT1F receptor antibody produced similar
pretation of the references to color in this figure legend, the reader isgonist an
quency.
ed by hy
mouse b
orescenc
ite circle
rrow). Name conditions used for RIPCre neuron recordings.
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K. Hisadome et al. / Neuroscience 159 (2009) 83–9390OMC neurons had a high mean input resistance of
.40.1 G and spontaneously fired action potentials
rom a mean resting membrane potential of 53.90.9
V (n40). As observed for RIPCre neurons, local appli-
ation of 5-HT (2 M) resulted in heterogeneous re-
ponses from POMC neurons, with 25% depolarized (10/
0), 12.5% hyperpolarized (5/40) and the remainder 62.5%
25/40) unaffected by this concentration of 5-HT. In neu-
ons, which displayed an inhibitory response to 5-HT there
as a rapid hyperpolarization (Fig. 7A) from a mean mem-
rane potential of 53.22.9 mV to 61.55.4 mV (n5,
0.05), which resulted in a decrease in neuronal firing
ate, from a mean value of 3.30.5 Hz to 0.50.3 Hz
P0.05). POMC neurons excited by 5-HT, were rapidly
epolarized (Fig. 7B) from a mean membrane potential of
55.92.5 mV to 48.34.0 mV (n10, P0.05). In
OMC neurons unaffected by application of 5-HT (Fig.
C), there was no significant change in either resting mem-
rane potential (52.60.9 mV to52.70.9 mV) or firing
ate (3.90.5 Hz to 4.40.7 Hz).
In order to determine whether the 5-HT-mediated hyperpo-
arization of POMC neurons was mediated by the same recep-
or-channel mechanism as described above for RIPCre neu-
ons, we examined the actions of BRL54443 on POMC neuron
xcitability. Local application of BRL54443 (20 nM) transiently
yperpolarized (Vm5.51.5 mV, P0.05) and reduced
he firing rate (Control12.55.0 Hz; BRL544435.93.6 Hz,
0.05) of POMC neurons (n4). Successive application of
RL54443 produced an identical hyperpolarizing response on
he same POMC neuron (Fig. 7D), although, in contrast to
IPCre neurons, POMC neurons displayed desensitization to
RL54443 (Fig. 7D) and 5-HT (data not shown), on re-applica-
ion of agonists within 5min of the first agonist challenge. Under
he same voltage clamp conditions described for RIPCre neu-
ons, BRL54443 (20 nM) reversibly increased the steady-state
epolarization-activated conductance (measured at10mV) in
ig. 6. BRL54443 increases IK, a delayed rectifier-type K
 current, in
urrents. The 5 ms pre-pulse to170 mV was used to deactivate any re
rom a RIPCre neuron elicited by a 10 mV voltage step in the absenc
mall effect of TEA on the transient, peak potassium current. (C) Repre
D) Expanded single test pulses to 10 mV, showing that BRL54443 i
ut had only a small effect on the peak transient current amplitude (inOMCneurons (Fig. 7E, F) by 3310%(P0.05,n4),with no Rhange in KIR slope conductance (1.50.4 versus 1.60.5 nS,
4) or IA amplitude (1028% of control, P	0.1, n4). These
ata indicate that 5-HT1F receptor activation, resulting in an
ncreased voltage-dependent potassium conductance, may un-
erlie the 5-HT-induced hyperpolarization of POMC neurons
escribed above.
DISCUSSION
he primary aim of this study was to examine the effect of
-HT on RIPCre neuron electrical excitability. It had previ-
usly been reported that 5-HT2C receptor agonists could
epolarize and excite POMC neurons (Heisler et al.,
002). Our results showed that although RIPCre neurons
ould be depolarized by 5-HT this was not the majority
esponse, with only 25% demonstrating an increase in
xcitability. In fact, half of all neurons tested displayed a
yperpolarizing, inhibitory, response to 5-HT application.
he 5-HT induced changes in excitability of RIPCre neu-
ons are likely to be predominantly directly mediated rather
han synaptically driven as similar responses are observed
n the presence of TTX in current clamp recordings. The
ncreased voltage-dependent potassium currents observed
n voltage-clamped RIPCre and POMC neurons in the pres-
nce of TTX and GABA and glutamate receptor antagonists
re also consistent with a direct effect of 5-HT on these
eurons. Previous studies of POMC and RIPCre neurons
ave demonstrated that peptide agonists and hormones do
ot elicit responses from every identified neuron (Cowley et
l., 2001; Choudhury et al., 2005; Plum et al., 2006; Smith et
l., 2007; Claret et al., 2007; Könner et al., 2007). It was
xpected that 5-HT would alter the excitability of RIPCre
eurons by one or more of the following receptor subtypes;
-HT1A,B, 5-HT2A,B,C or 5-HT7, as these have been shown to
e expressed in the medial hypothalamus or arcuate, and
mplicated in 5-HT modulation of feeding (Hoyer et al., 2002;
neurons. (A) Voltage clamp pulse protocol for recording of potassium
ltage dependent potassium conductance. (B) Representative currents
esence of bath-applied TEA (40 mM). Inset traces show the relatively
current families in the absence and presence of BRL54443 (20 nM).
the steady-state current amplitude, which was reversed on washout,
nded traces).RIPCre
sidual vo
e and pr
sentative
ncreasedamos et al., 2005). Indeed, we reasoned that RIPCre neu-
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K. Hisadome et al. / Neuroscience 159 (2009) 83–93 91on depolarization could occur through the same receptor
echanism reported for POMC neurons. However, surprisingly
e were unable to demonstrate, using selective 5-HT2A,2B,2C
ntagonists and a selective 5-HT2B agonist that the 5-HT-in-
uced depolarization of RIPCre neurons was due to any of
hese subtypes. Clearly the receptor subtype and identity of the
hannel mechanisms underlying the 5-HT depolarization of
IPCre neurons will require further analysis.
5-HT-induced hyperpolarization of RIPCre neurons was
nlikely to be mediated by a member of the 5-HT2 family as
-me 5-HT was ineffective, the 5-HT responses were insen-
itive to 5-HT2A,B,C antagonists and a selective 5-HT2B ago-
ist. In contrast, the observation that 5-CT hyperpolarized
IPCre neurons suggested that the receptor underlying the
-HT hyperpolarization is amember of the 5HT1 family, or the
-HT or 5-HT receptor. However, the lack of effect of 8-
ig. 7. POMC neurons exhibit heterogeneous electrical responses to 5-H
xcited (B) by locally-applied 5-HT. Expanded traces and the correspondin
eurons, challenged with 5-HT (local application), exhibited no Vm or o
20 nM) hyperpolarization of a POMC neuron. Expanded traces are sho
RL54443 (20 nM) 3 min after the first was unable to elicit a response,
ignificant hyperpolarization and reduction in firing. (E, F) BRL54443 re
eurons. Representative current families in the absence and presence of
o demonstrate this action of BRL54443 is reversible and limited to the s5 7
H-DPAT, CGS12066B and L694247 as agonists and SB s24289 and sub-micromolar methiothepin as antagonists
o 5-HT-mediated hyperpolarization, effectively ruled out
-HT1A,B,D and 5-HT5,7 receptors as responsible. The obser-
ation that low concentrations (10 or 20 nM) of the mixed
-HT1E,F receptor agonist, BRL54443 hyperpolarized and
hat micromolar concentrations of methiothepin prevented
-HT induced hyperpolarization of RIPCre neurons indicates
hat one of these subtypes is likely responsible. Unfortu-
ately, no selective 5-HT1F receptor agonist or antagonist
as available to allow us to distinguish between these 5-HT
eceptor isoforms, but as mice do not possess the gene for
-HT1E receptors (Bai et al., 2004) we suggest that the 5-HT-
nduced hyperpolarization of RIPCre neurons is mediated by
ctivation of the 5-HT1F receptor. The human cloned 5-HT1F
eceptor has previously been demonstrated to require a me-
hiothepin concentration of 1 M to inhibit a functional re-
le of a POMC neuron hyperpolarized and inhibited (A) or depolarized and
ot of firing frequency for this neuron are shown. (C) Themajority of POMC
equency, as shown in the expanded traces. (D) Example of BRL54443
for each agonist application ((i)–(iii)). Note that a second application of
after 9 min an increased dose of BRL54443 was required to produce
creased the amplitude of the steady-state potassium current in POMC
3 (20 nM) are shown (E) with expanded single test pulses to10 mV (F)
te, not the peak, potassium current amplitude.T. Examp
g diary pl
f firing fr
wn below
and even
versibly inponse (Adham et al., 1993). Previous studies have indicated
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K. Hisadome et al. / Neuroscience 159 (2009) 83–9392hat mRNA for the 5-HT1F receptor is present in human brain
Hoyer et al., 1994, 2002), and in situ hybridization studies of
ouse brain indicate its presence in numerous regions, in-
luding the hypothalamus (Bonnin et al., 2006). In support of
his contention, mRNA for the 5-HT1F receptor was detected
y PCR in mouse hypothalamus in agreement with a previ-
us study in rat (Lovenberg et al., 1993). Furthermore, im-
unohistochemical analysis of mouse ARC slices, using two
eparate antibodies to the 5-HT1F receptor demonstrated its
xpression in most RIPCre neurons as well as other, unde-
ned, neurons in the ARC. BRL54443 increased current
hrough a channel that has the basic characteristics of a
teady-state, delayed rectifier-like potassium channel with no
ffect on KIR or IA, the other major potassium currents
resent in these neuron types (Smith et al., 2007). Previous
tudies have demonstrated that a number of 5-HT receptor
ubtypes are capable of coupling to K channels although
his appears primarily mediated via Ca2-activated K chan-
els or G-protein-gated inwardly rectifying K channels (Ray-
ond et al., 2001), rather than the delayed rectifier family of
 channels. Although we demonstrate that BRL54443 in-
reases the current through a voltage-gated potassium con-
uctance, it is unlikely that the typical delayed rectifier or IA
otassium channels (i.e. Kv1–4 families) underlie the 5-HT-
ediated hyperpolarization. 5-HT and BRL54443 hyperpo-
arize RIPCre and POMC neurons from a membrane poten-
ial of 50 to 55 mV, a range where most delayed rectifier
hannels are closed. One plausible candidate group of volt-
ge-gated potassium channels is the KCNQ gene family.
hese encode Kv7 channel subunits, which are expressed
idely in the brain, exhibit voltage dependent activation, are
unctionally active at the resting membrane potential of many
eurons and can be modulated by neurotransmitters (Han-
en et al., 2008). Additionally, the coupling mechanism by
hich this 5-HT receptor increases potassium channel cur-
ent is presently unknown. Studies of the human 5-HT1F
eceptor, expressed in 3T3 or fibroblast cell lines, indicate
hat this receptor subtype is capable of engaging with multiple
ell signal transduction pathways (i.e. cAMP, inositol phos-
hates and intracellular calcium), in a cell-specific manner
Adham et al., 1993).
Our results do support the contention that at least part
f the anorexigenic actions of 5-HT in the hypothalamus
ay be via the central melanocortin system (Heisler et al.,
002, 2006). Indeed, the main action of 5-HT on identified
OMC neurons, albeit on a minority of the population
25%) we sampled in the arcuate, was depolarization and
ncreased excitation in agreement with the previous report
Heisler et al., 2002). This result is consistent with the
eport that low concentrations of 5-HT directly stimulate
-MSH release from POMC neurons in the hypothalamus
Tiligada and Wilson, 1989). However, POMC neurons can
lso respond to 5-HT by hyperpolarization and inhibition of
ring, and our current clamp and voltage clamp data using
RL54443 as an agonist, suggest this outcome may also be
riven by the same 5-HT receptor-voltage-activated potas-
ium channel mechanism described for ARC RIPCre neu-
ons. Thus, POMC neurons also appear capable of divergent
lectrical responses to 5-HT and this may be linked to differ-ntial outputs, such as altered food intake and energy expen-
iture or modulation of peripheral glucose levels or fat stor-
ge, sub-served by different groups of POMC neurons
Cone, 2005). Indeed, there is additional evidence that mul-
iple 5-HT-dependent mechanisms contribute to modulation
f POMC neuron excitability as Heisler et al. (2006) have
hown that 5-HT, by activating 5-HT1B receptors on NPY/
gRP neurons, can reduce the inhibitory drive onto POMC
eurons (i.e. indirect excitation).
The responses of the RIPCre neurons investigated
ere indicate that the predominant action of 5-HT is to
yperpolarize, and inhibit, these neurons. This occurs
hrough activation of a voltage-gated K conductance and
s likely mediated by the 5-HT1F receptor subtype. Unfor-
unately, it is not yet possible to judge the physiological
ignificance of this inhibition of RIPCre neuron function, or
ts potential relation to 5-HT-mediated physiological out-
omes such as reduced food consumption or mood alter-
tion. This is because we do not presently know the iden-
ity of the transmitter(s)/peptide(s) released from this neu-
onal population, nor how these neurons relate to the
PY/AgRP and POMC neuron ARC circuitry, although
here is evidence to suggest that RIPCre neurons may be
art of the melanocortin system (Choudhury et al., 2005;
mith et al., 2007).
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